国际医药卫生导报2023年8月第29卷第16期IMHGN,August2023,Vol.29,No.16[26]YeY,BajajM,YangHC,etal.SGLT-2InhibitionwithDapagliflozinreducestheactivationoftheNlrp3/ASCInflammasomeandattenuatesthedevelopmentofdiabeticcardiomyopathyinmicewithtype2diabetes.FurtherAugmentationoftheeffectswithsaxagliptin,aDPP4inhibitor[J].CardiovascDrugsTher,2017,31(2):119-132.DOI:10.1007/s10557-017-6725-2.[27]XueM,LiT,WangY,etal.EmpagliflozinpreventscardiomyopathyviasGC-cGMP-PKGpathwayintype2diabetesmice[J].ClinSci(Lond),2019,133(15):1705-1720.DOI:10.1042/CS20190585.[28]CheH,WangY,LiH,etal.MelatoninalleviatescardiacfibrosisviainhibitinglncRNAMALAT1/miR-141-mediatedNLRP3inflammasomeandTGF-β1/Smadssignalingindiabeticcardiomyopathy[J].FASEBJ,2020,34(4):5282-5298.DOI:10.1096/fj.201902692R.[29]LuoB,LiB,WangW,etal.RosuvastatinalleviatesdiabeticcardiomyopathybyinhibitingNLRP3inflammasomeandMAPKpathwaysinatype2diabetesratmodel[J].CardiovascDrugsTher,2014,28(1):33-43.DOI:10.1007/s10557-013-6498-1.[30]ZhangH,ChenX,ZongB,etal.GypenosidesimprovediabeticcardiomyopathybyinhibitingROS-mediatedNLRP3inflammasomeactivation[J].JCellMolMed,2018,22(9):4437-4448.DOI:10.1111/jcmm.13743.[31]YanM,LiL,WangQ,etal.TheChineseherbalmedicineFufangZhenzhuTiaozhiprotectsagainstdiabeticcardiomyopathybyalleviatingcardiaclipotoxicity-inducedoxidativestressandNLRP3-dependentinflammasomeactivation[J].BiomedPharmacother,2022,148:112709.DOI:10.1016/j.biopha.2022.112709.[32]JiangC,LiD,ChenL,etal.Quercetinamelioratedcardiacinjuryviareducinginflammatoryactionsandtheglycerophospholipidmetabolismdysregulationinadiabeticcardiomyopathymousemodel[J].FoodFunct,2022,13(14):7847-7856.DOI:10.1039/d2fo00912a.[33]WenY,GengL,ZhouL,etal.BetulinalleviatesonmyocardialinflammationindiabetesmiceviaregulatingSiti1/NLRP3/NF-κBpathway[J].IntImmunopharmacol,2020,85:106653.DOI:10.1016/j.intimp.2020.106653.肠道菌群与代谢性疾病关系研究进展方建锋中国人民解放军95019部队医院全科，襄阳441800Email：609495858@qq.com【摘要】代谢性疾病是一系列机体代谢异常疾病的...
